Gujarat Kidney and Super Speciality informs about outcome of board meeting

02 Jan 2026 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with Schedule III to the Listing Regulations, Gujarat Kidney and Super Speciality has informed that the Board of Directors of the Company, at its Meeting held today, on Friday, 2nd January, 2025 (which commenced at 10:00 am and concluded at 11:00 am), has approved the following:- 1) APPROVAL FOR ACQUISITION OF 100% EQUITY STAKE IN PAREKHS HOSPITAL AND FOR EXECUTION OF SHARE PURCHASE AGREEMENT WITH THE PROMOTER GROUP OF PAREKHS HOSPITAL: The Board of Directors has approved the purchase / acquisition of 100% Equity Stake in Parekhs Hospital to make that Company as a wholly owned subsidiary of the Company. The details as required under Regulation 30, read with Para A (7) of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November 2024 has been provided in Annexure-A.

The above information is a part of company’s filings submitted to BSE.

Guj. Kidney & Super Share Price

102.45 -0.90 (-0.87%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7259.55
Max Healthcare Inst 1016.90
Narayana Hrudayalay 1896.70
Aster DM Healthcare 613.55
Global Health 1176.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×